University Medical and Pharmacy Hospital of Ho Chi Minh City and Novartis Vietnam continue to sign a strategic cooperation for the 2025‑2027 period

On November 19, 2025, the University Medical and Pharmacy Hospital of Ho Chi Minh City (BV ĐHYD) and Novartis Vietnam Co., Ltd. (Novartis Vietnam) signed a memorandum of understanding for cooperation for the 2025-2027 period, aiming to promote medical innovation, expand clinical research, enhance training capacity, and contribute to optimizing treatment effectiveness for patients in Vietnam.

According to the memorandum of understanding between the two parties, the cooperation focuses on four key areas:
✅ Build and develop a Center of Excellence model (Center of Excellence)
✅ Ongoing medical training and enhancing the capacity of healthcare personnel
✅ Accelerate clinical research collaboration according to international standards
✅ Strengthen the implementation of patient-oriented programs (Patient-oriented Programs)

From 2021 to present, together with the partnership of Novartis Vietnam, Da Nang Hospital (BV ĐHYD) has launched many initiatives to enhance treatment capacity, research and medical training, such as: Heart Failure Management Clinic (Heart Failure Clinic) (2021-2024); Spondyloarthritis Specialty Clinic (SpA Clinic) (2022); Health Transplant Project for transplant patients - UMC Health Transplant Project (2023-2025); Lipid Disorder Control Center (Lipid Control Center - LCC) (2024-2025). In the upcoming period, both parties will continue to expand cooperation in key areas, including improving treatment effectiveness, developing professional training programs and promoting global clinical research.

Assessing the partnership with Novartis, Associate Professor Dr. Nguyen Hoang Dinh - Deputy Director of the Hospital, emphasized: “With the vision and direction to become a leading university hospital in Vietnam and meet international standards, Da Nang Hospital is always committed to providing optimal health care solutions through the integration of treatment, research and training. Over the past years, the Hospital has focused on developing high‑quality human resources, enhancing professional capacity, standardizing processes, promoting digital transformation and expanding global clinical research. Continuing to sign a memorandum of understanding with Novartis Vietnam this time contributes to expanding the network of strategic partners accompanying the Hospital, bringing many new opportunities in training, treatment and helping realize the vision of an innovative medical field for people's health.”

Speaking at the ceremony, Mr. Jondy Syjuco - National Director, Novartis Vietnam, said: “We are proud to be a trusted partner of the Vietnamese healthcare system in general and of BV ĐHYD in particular. The signing of the Comprehensive Cooperation Memorandum of Understanding with BV ĐHYD today is a concrete testament to our commitment to accompany Vietnam's healthcare system in realizing the vision of an innovative, sustainable, patient‑centric healthcare system. By combining Novartis's global research strengths and innovative capabilities with the expertise of leading hospitals, we will continue to promote clinical research, enhance medical capacity, and apply technology in healthcare, enabling patients in Vietnam to access advanced, high‑quality treatments earlier.”

With the vision of promoting medical innovation, the memorandum of understanding between BV ĐHYD and Novartis Vietnam not only strengthens the strategic partnership between the two parties, but also contributes to advancing the national healthcare transformation, enhancing professional capacity, and delivering tangible benefits to patients in Vietnam.